Stockreport

Will VLRX-L Preclinical Dosing Signal a New Pipeline Chapter for Clinuvel Pharmaceuticals (ASX:CUV) Narrative [Yahoo! Finance]

CLINUVEL PHARMS LTD S/ADR  (CLVLY) 
NASDAQ:AMEX Investor Relations: clinuvel.com/investors
PDF This step could be important because successful development of VLRX-L may allow Clinuvel to broaden its pipeline with products based on its own intellectual property. [Read more]